Mucosal immunogens for novel vaccines

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 932, 4242441, 4352523, 4352528, A61K 3902, A61K 3909, C12N 121

Patent

active

060306246

ABSTRACT:
The present invention provides chimeric proteins such as Salivary Binding Protein (SBR) coupled to the B subunit of cholera toxin. Such a chimeric protein, when expressed in attenuated Salmonella typhymurium produces significant increases in serum IgG and salivary IgA antibody levels after oral immunization. In another embodiment of the present invention, the recombinant plasmid contains a salivary binding protein-cholera toxin A2/B chimeric protein expressed in E. coli. Intragastric immunization of SBR coupled to CTB in this chimeric protein form leads to increased antigen responsive T cells. In another embodiment of the present invention, the recombinant plasmid contains a salivary binding protein-cholera toxin.sup..DELTA.A1 chimeric protein expressed in Salmonella typhimurium. Oral immunization using this recombinant plasmid results in increased serum IgG responses to antigen. Oral immunization using this recombinant plasmid also resulted in increased salivary IgA antibody responses to antigen.

REFERENCES:
Hajishengallis et al. Journal of Immunology 154 (9): 4322-32, May 1, 1995.
Redman et al . Infection and Immunity 63 (5): 2004-2011, May 1995.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mucosal immunogens for novel vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mucosal immunogens for novel vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mucosal immunogens for novel vaccines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-680270

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.